StockMap tracks 390 large-cap U.S. stocks in the Biotechnology industry. Their combined market capitalisation is $2.28T. On the most recent trading day the industry was down 2.17% on average. Its largest constituents by market capitalisation are ABBV, AMGN, GILD, VRTX, REGN. Every stock in this industry carries a conviction signal and a two-week outlook, and calls that lean one way are graded in public once their window closes.
| Symbol | Name | Cap |
|---|---|---|
| ABBV | AbbVie | $521.11B |
| AMGN | Amgen | $251.94B |
| GILD | Gilead Sciences | $211.64B |
| VRTX | Vertex Pharmaceuticals Incorporated | $141.65B |
| REGN | Regeneron Pharmaceuticals | $95.53B |
| MRNA | Moderna | $88.52B |
| NTRA | Natera | $59.72B |
| ARGX | argenx | $55.84B |
| RVMD | Revolution Medicines | $41.00B |
| ONC | BeOne Medicines | $40.66B |
| BIIB | Biogen | $37.49B |
| GMAB | Genmab A/S ADS | $35.06B |
| ROIV | Roivant Sciences Ltd. Common Shares | $26.66B |
| UTHR | United Therapeutics | $25.68B |
| INSM | Insmed Incorporated | $24.70B |
| INCY | Incyte | $24.54B |
| BNTX | BioNTech SE American Depositary Share | $22.15B |
| ALNY | Alnylam Pharmaceuticals | $22.10B |
| EXEL | Exelixis | $16.93B |
| ASND | Ascendis Pharma A/S Ordinary Share | $16.68B |
| HALO | Halozyme Therapeutics | $14.86B |
| NBIX | Neurocrine Biosciences | $14.85B |
| BBIO | BridgeBio Pharma | $14.60B |
| SMMT | Summit Therapeutics | $12.82B |
| BMRN | BioMarin Pharmaceutical | $11.33B |
| KYMR | Kymera Therapeutics | $10.81B |
| TWST | Twist Bioscience | $10.12B |
| MDGL | Madrigal Pharmaceuticals | $9.94B |
| KRYS | Krystal Biotech | $9.84B |
| CAI | Caris Life Sciences | $9.70B |
| PCVX | Vaxcyte | $9.44B |
| PTGX | Protagonist Therapeutics | $9.37B |
| TGTX | TG Therapeutics | $9.36B |
| SYRE | Spyre Therapeutics | $8.90B |
| CYTK | Cytokinetics Incorporated | $8.76B |
| ARWR | Arrowhead Pharmaceuticals | $8.46B |
| PRAX | Praxis Precision Medicines | $7.98B |
| ALKS | Alkermes | $7.61B |
| KNSA | Kiniksa Pharmaceuticals International | $7.25B |
| IONS | Ionis Pharmaceuticals | $7.23B |
| ABVX | Abivax SA | $6.91B |
| ORKA | Oruka Therapeutics | $6.41B |
| GRAL | GRAIL | $6.41B |
| RYTM | Rhythm Pharmaceuticals | $6.37B |
| KOD | Kodiak Sciences | $6.23B |
| IMVT | Immunovant | $6.03B |
| CGON | CG Oncology Inc. Common stock | $5.73B |
| MIRM | Mirum Pharmaceuticals | $5.52B |
| COGT | Cogent Biosciences | $5.38B |
| SRRK | Scholar Rock Holding | $5.35B |
| ERAS | Erasca | $5.02B |
| PTCT | PTC Therapeutics | $5.01B |
| CRSP | CRISPR Therapeutics AG Common Shares | $4.97B |
| TVTX | Travere Therapeutics | $4.75B |
| DNTH | Dianthus Therapeutics | $4.61B |
| CDNA | CareDx | $4.59B |
| LEGN | Legend Biotech | $4.21B |
| ARQT | Arcutis Biotherapeutics | $4.03B |
| RLAY | Relay Therapeutics | $4.02B |
| VCYT | Veracyte | $4.02B |
| IOVA | Iovance Biotherapeutics | $3.84B |
| TNGX | Tango Therapeutics | $3.83B |
| XENE | Xenon Pharmaceuticals Inc. Common Shares | $3.62B |
| IRON | Disc Medicine | $3.58B |
| ACAD | ACADIA Pharmaceuticals | $3.55B |
| VKTX | Viking Therapeutics | $3.48B |
| PBLS | Parabilis Medicines | $3.45B |
| CELC | Celcuity | $3.38B |
| DYN | Dyne Therapeutics | $3.12B |
| TLX | Telix Pharmaceuticals | $3.10B |
| IDYA | IDEAYA Biosciences | $3.08B |
| DNLI | Denali Therapeutics | $3.03B |
| NRIX | Nurix Therapeutics Inc. Common stock | $2.93B |
| BEAM | Beam Therapeutics | $2.81B |
| VRDN | Viridian Therapeutics | $2.79B |
| ZLAB | Zai Lab | $2.76B |
| RCUS | Arcus Biosciences | $2.61B |
| ADMA | ADMA Biologics | $2.56B |
| PGEN | Precigen | $2.48B |
| NAMS | NewAmsterdam Pharma Company | $2.40B |
| RXRX | Recursion Pharmaceuticals | $2.40B |
| CLDX | Celldex Therapeutics | $2.36B |
| BHVN | Biohaven Ltd. Common Shares | $2.33B |
| VERA | Vera Therapeutics | $2.23B |
| XNCR | Xencor | $2.22B |
| AUPH | Aurinia Pharmaceuticals | $2.22B |
| BCRX | BioCryst Pharmaceuticals | $2.16B |
| IMNM | Immunome | $2.15B |
| LKFT | Lakefront Biotherapeutics | $2.12B |
| PVLA | Palvella Therapeutics | $2.11B |
| GRFS | Grifols | $2.09B |
| VCEL | Vericel | $2.06B |
| ZYME | Zymeworks | $2.02B |
| MESO | Mesoblast | $1.97B |
| SRPT | Sarepta Therapeutics Inc. Common Stock (DE) | $1.97B |
| SLS | SELLAS Life Sciences Group | $1.95B |
| COAG | Hemab Therapeutics Holdings | $1.94B |
| VIR | Vir Biotechnology | $1.91B |
| ABSI | Absci | $1.91B |
| TRAX | First Tracks Biotherapeutics | $1.89B |
| GENB | Generate Biomedicines | $1.86B |
| ZBIO | Zenas BioPharma | $1.85B |
| AGIO | Agios Pharmaceuticals | $1.82B |
| NTLA | Intellia Therapeutics | $1.75B |
| QURE | uniQure | $1.72B |
| STOK | Stoke Therapeutics | $1.70B |
| REPL | Replimune Group | $1.67B |
| KLRA | Kailera Therapeutics | $1.67B |
| NVAX | Novavax | $1.66B |
| ALVO | Alvotech | $1.66B |
| MLYS | Mineralys Therapeutics | $1.61B |
| CMPS | COMPASS Pathways Plc American Depository Shares | $1.60B |
| URGN | UroGen Pharma | $1.60B |
| IMCR | Immunocore Holdings | $1.59B |
| RARE | Ultragenyx Pharmaceutical | $1.59B |
| NBTX | Nanobiotix | $1.52B |
| TYRA | Tyra Biosciences | $1.45B |
| ANAB | AnaptysBio | $1.44B |
| AAPG | Ascentage Pharma Group International American Depository Shares | $1.36B |
| TSHA | Taysha Gene Therapies | $1.35B |
| NKTR | Nektar Therapeutics | $1.33B |
| DMRA | Damora Therapeutics | $1.33B |
| SLN | Silence Therapeutics Plc American Depository Share | $1.23B |
| SNDX | Syndax Pharmaceuticals | $1.22B |
| VOR | Vor Biopharma | $1.21B |
| VSTM | Verastem | $1.18B |
| MNKD | MannKind | $1.13B |
| IMTX | Immatics | $1.10B |
| JANX | Janux Therapeutics | $1.07B |
| INBX | Inhibrx Biosciences | $1.06B |
| MLTX | MoonLake Immunotherapeutics | $1.00B |
| SVRA | Savara | $990.32M |
| CGEM | Cullinan Therapeutics | $967.26M |
| RIGL | Rigel Pharmaceuticals | $958.47M |
| ORIC | Oric Pharmaceuticals | $957.75M |
| ODTX | Odyssey Therapeutics | $939.07M |
| GLUE | Monte Rosa Therapeutics | $917.97M |
| KURA | Kura Oncology | $912.74M |
| MGTX | MeiraGTx Holdings | $911.45M |
| JBIO | Jade Biosciences | $894.17M |
| PHAR | Pharming Group N.V. ADS each representing 10 ordinary shares | $866.25M |
| IVA | Inventiva S.A. American Depository Shares | $862.42M |
| AKTS | Aktis Oncology Inc. Common stock | $856.19M |
| PRME | Prime Medicine | $856.10M |
| CRVS | Corvus Pharmaceuticals | $843.73M |
| ABUS | Arbutus Biopharma | $834.03M |
| SANA | Sana Biotechnology | $769.36M |
| ANNX | Annexon | $767.79M |
| ARDX | Ardelyx | $755.04M |
| AVBP | ArriVent BioPharma | $733.21M |
| ACHV | Achieve Life Sciences Inc. Common Shares | $702.82M |
| SGMT | Sagimet Biosciences Inc. Series A | $699.69M |
| ANL | Adlai Nortye Group | $669.08M |
| DSGN | Design Therapeutics | $668.38M |
| SLDB | Solid Biosciences | $664.79M |
| FDMT | 4D Molecular Therapeutics | $657.40M |
| CADL | Candel Therapeutics | $637.40M |
| AURA | Aura Biosciences | $636.75M |
| IMMX | Immix Biopharma | $636.66M |
| OLMA | Olema Pharmaceuticals | $612.49M |
| MYGN | Myriad Genetics | $607.38M |
| BCAX | Bicara Therapeutics | $604.16M |
| NVCT | Nuvectis Pharma | $602.12M |
| DBVT | DBV Technologies | $596.40M |
| CLYM | Climb Bio | $588.72M |
| IRWD | Ironwood Pharmaceuticals | $578.34M |
| GERN | Geron | $574.63M |
| MDXG | MiMedx Group | $566.19M |
| STTK | Shattuck Labs | $558.02M |
| ENTX | Entera Bio | $556.55M |
| NGNE | Neurogene | $551.30M |
| PBYI | Puma Biotechnology | $538.91M |
| SRZN | Surrozen | $516.91M |
| VALN | Valneva | $516.79M |
| CTMX | CytomX Therapeutics | $509.88M |
| CBIO | Crescent Biopharma | $500.70M |
| DMAC | DiaMedica Therapeutics | $498.82M |
| OVID | Ovid Therapeutics | $496.06M |
| RCEL | Avita Medical | $484.01M |
| GYRE | Gyre Therapeutics | $482.98M |
| FTH | Faeth Therapeutics | $482.95M |
| RGNX | REGENXBIO | $475.29M |
| MNPR | Monopar Therapeutics | $471.99M |
| KMDA | Kamada | $444.14M |
| EPRX | Eupraxia Pharmaceuticals | $444.08M |
| PRTA | Prothena | $434.82M |
| MPLT | MapLight Therapeutics | $421.27M |
| YDES | YD Bio | $420.81M |
| CCCC | C4 Therapeutics | $414.59M |
| EDIT | Editas Medicine | $410.06M |
| ASMB | Assembly Biosciences | $409.87M |
| ALLO | Allogene Therapeutics | $407.68M |
| AUTL | Autolus Therapeutics plc American Depositary Share | $404.57M |
| ALT | Altimmune | $396.82M |
| ZURA | Zura Bio | $389.15M |
| TECX | Tectonic Therapeutic | $386.68M |
| AVTX | Avalo Therapeutics | $384.53M |
| RZLT | Rezolute Inc. Common Stock (NV) | $382.08M |
| CAPR | Capricor Therapeutics | $370.93M |
| FENC | Fennec Pharmaceuticals | $358.99M |
| KYTX | Kyverna Therapeutics | $350.65M |
| EBS | Emergent BioSolutions | $349.17M |
| SPRY | ARS Pharmaceuticals | $336.13M |
| GALT | Galectin Therapeutics | $334.82M |
| XFOR | X4 Pharmaceuticals | $332.14M |
| ALEC | Alector | $327.65M |
| ARCT | Arcturus Therapeutics Holdings | $313.51M |
| ENTA | Enanta Pharmaceuticals | $311.93M |
| PRLD | Prelude Therapeutics Incorporated | $309.64M |
| AGEN | Agenus | $307.94M |
| IRD | Opus Genetics | $305.33M |
| BNTC | Benitec Biopharma | $304.93M |
| SABS | SAB Biotherapeutics | $304.80M |
| EIKN | Eikon Therapeutics | $287.62M |
| ANIK | Anika Therapeutics | $280.37M |
| LYEL | Lyell Immunopharma | $270.54M |
| RCKT | Rocket Pharmaceuticals | $267.85M |
| QTTB | Q32 Bio | $265.24M |
| LXEO | Lexeo Therapeutics | $257.77M |
| LRMR | Larimar Therapeutics | $256.59M |
| BCYC | Bicycle Therapeutics | $256.54M |
| CABA | Cabaletta Bio | $256.01M |
| CUVL | Clinuvel Pharmaceuticals | $255.97M |
| AMRN | Amarin | $255.80M |
| GLSI | Greenwich LifeSciences | $255.54M |
| FATE | Fate Therapeutics | $249.23M |
| ABEO | Abeona Therapeutics | $248.75M |
| CAMP | CAMP4 Therapeutics | $248.50M |
| IFRX | InflaRx | $244.63M |
| EVMN | Evommune | $244.25M |
| IMRX | Immuneering | $242.54M |
| OCGN | Ocugen | $238.29M |
| VNDA | Vanda Pharmaceuticals | $229.18M |
| TLSI | TriSalus Life Sciences | $227.83M |
| ACIU | AC Immune SA | $225.94M |
| ELDN | Eledon Pharmaceuticals | $225.09M |
| KROS | Keros Therapeutics | $218.89M |
| IKT | Inhibikase Therapeutics | $216.28M |
| KRRO | Korro Bio | $210.80M |
| BBOT | BridgeBio Oncology Therapeutics | $210.06M |
| XGN | Exagen | $208.09M |
| ARTV | Artiva Biotherapeutics | $204.85M |
| RNAC | Cartesian Therapeutics | $196.35M |
| PRQR | ProQR Therapeutics | $196.16M |
| ADCT | ADC Therapeutics SA Common Shares | $195.33M |
| DTIL | Precision BioSciences | $194.87M |
| ACOG | Alpha Cognition | $190.34M |
| UPB | Upstream Bio | $186.77M |
| ZNTL | Zentalis Pharmaceuticals | $185.55M |
| WHWK | Whitehawk Therapeutics | $184.71M |
| RNA | Atrium Therapeutics | $184.22M |
| TRDA | Entrada Therapeutics | $176.58M |
| SION | Sionna Therapeutics | $174.97M |
| ADAG | Adagene | $168.53M |
| IPHA | Innate Pharma S.A. ADS | $163.08M |
| CNTN | Canton Strategic Holdings | $155.38M |
| MGNX | MacroGenics | $152.88M |
| ALXO | ALX Oncology Holdings | $152.41M |
| CUE | Cue Biopharma | $151.60M |
| STRO | Sutro Biopharma | $150.89M |
| NNNN | Anbio Biotechnology | $147.47M |
| TARA | Protara Therapeutics | $146.56M |
| MSLE | Satellos Bioscience | $142.15M |
| CMPX | Compass Therapeutics | $141.64M |
| NBP | NovaBridge Biosciences | $140.67M |
| MOLN | Molecular Partners | $137.13M |
| SPRB | Spruce Biosciences | $133.32M |
| CATX | Perspective Therapeutics | $131.27M |
| KZIA | Kazia Therapeutics | $129.59M |
| CHRS | Coherus Oncology | $128.25M |
| FHTX | Foghorn Therapeutics | $123.52M |
| ARMP | Armata Pharmaceuticals | $121.96M |
| BNR | Burning Rock Biotech | $114.65M |
| OTLK | Outlook Therapeutics | $113.96M |
| NKTX | Nkarta | $111.73M |
| NERV | Minerva Neurosciences | $110.78M |
| AVXL | Anavex Life Sciences | $110.31M |
| ANIX | Anixa Biosciences | $108.46M |
| VYGR | Voyager Therapeutics | $105.98M |
| PDSB | PDS Biotechnology | $104.36M |
| UNCY | Unicycive Therapeutics | $104.18M |
| ENGN | enGene Therapeutics | $102.53M |
| IMUX | Immunic | $102.47M |
| BDTX | Black Diamond Therapeutics | $102.27M |
| VTVT | vTv Therapeutics | $99.52M |
| PMVP | PMV Pharmaceuticals | $98.92M |
| ORGO | Organogenesis Holdings | $98.84M |
| IMDX | Insight Molecular Diagnostics | $96.86M |
| ICCC | ImmuCell | $93.18M |
| TNXP | Tonix Pharmaceuticals Holding | $87.47M |
| EQ | Equillium | $86.87M |
| COYA | Coya Therapeutics | $84.68M |
| RLYB | Rallybio | $83.67M |
| CRBP | Corbus Pharmaceuticals Holdings | $81.62M |
| ATRA | Atara Biotherapeutics | $80.40M |
| CLLS | Cellectis | $78.51M |
| CRDF | Cardiff Oncology | $69.21M |
| TENX | Tenax Therapeutics | $66.99M |
| FBIO | Fortress Biotech | $64.03M |
| GOSS | Gossamer Bio | $63.48M |
| SPRO | Spero Therapeutics | $61.73M |
| APLM | Apollomics | $60.31M |
| NMAD | Nomad Power Solutions | $57.32M |
| XBIT | XBiotech | $57.32M |
| CLNN | Clene | $54.44M |
| INKT | MiNK Therapeutics | $53.73M |
| XLO | Xilio Therapeutics | $52.84M |
| HRTX | Heron Therapeutics | $52.72M |
| IBIO | iBio | $49.43M |
| KLRS | Kalaris Therapeutics | $48.32M |
| ANVS | Annovis Bio | $48.23M |
| IMA | ImageneBio | $46.54M |
| ATNM | Actinium Pharmaceuticals Inc. (Delaware) | $46.53M |
| MREO | Mereo BioPharma Group | $46.23M |
| TIL | Instil Bio | $46.12M |
| ELTX | Elicio Therapeutics | $45.51M |
| INMB | INmune Bio Inc. Common stock | $44.89M |
| ATHE | Alterity Therapeutics | $41.25M |
| EXOZ | eXoZymes | $38.43M |
| TVGN | Tevogen | $38.42M |
| PTHS | Pelthos Therapeutics | $36.96M |
| GRDX | GridAI Technologies | $35.37M |
| EDSA | Edesa Biotech Inc. Common Shares | $34.71M |
| NNVC | NanoViricides | $33.95M |
| ALDX | Aldeyra Therapeutics | $33.80M |
| ACET | Adicet Bio | $32.01M |
| ALGS | Aligos Therapeutics | $29.98M |
| PMN | ProMIS Neurosciences Inc. Common Shares (ON) | $29.68M |
| NXTC | NextCure | $28.88M |
| RNAZ | TransCode Therapeutics | $27.60M |
| BYSI | BeyondSpring | $26.47M |
| BCTX | BriaCell Therapeutics Corp. Common Shares | $26.45M |
| EVAX | Evaxion A/S American Depositary Share | $26.43M |
| PLRZ | Polyrizon | $25.50M |
| SHPH | Shuttle Pharmaceuticals Holdings | $24.54M |
| CVM | Cel-Sci | $24.27M |
| CRVO | CervoMed | $24.19M |
| IMMP | Immutep | $22.56M |
| QNRX | Quoin Pharmaceuticals | $21.81M |
| ATOS | Atossa Therapeutics | $21.65M |
| AKTX | Akari Therapeutics plc ADS | $18.83M |
| KYNB | Kyntra Bio | $18.50M |
| MCRB | Seres Therapeutics | $17.60M |
| BOLT | Bolt Biotherapeutics | $17.04M |
| RADX | Radiopharm Theranostics | $16.96M |
| NEUP | Neuphoria Therapeutics | $16.50M |
| MRKR | Marker Therapeutics | $16.34M |
| AQB | AquaBounty Technologies | $15.82M |
| DYAI | Dyadic International | $15.23M |
| NCEL | NewcelX | $13.73M |
| BCDA | BioCardia | $13.03M |
| PBM | Psyence Biomedical Ltd. Common Shares | $12.62M |
| BIVI | BioVie | $12.20M |
| CLRB | Cellectar Biosciences | $11.39M |
| PASG | Passage Bio | $11.10M |
| INTS | Intensity Therapeutics Inc. Common stock | $11.10M |
| LSTA | Lisata Therapeutics | $11.02M |
| GTBP | GT Biopharma | $10.96M |
| PHIO | Phio Pharmaceuticals | $9.99M |
| BLRX | BioLineRx | $9.91M |
| LTRN | Lantern Pharma | $9.87M |
| RGNT | Regentis Biomaterials | $9.62M |
| CLGN | CollPlant Biotechnologies | $9.36M |
| PTN | Palatin Technologies | $8.90M |
| MBRX | Moleculin Biotech | $8.29M |
| SNGX | Soligenix | $7.75M |
| VTGN | Vistagen Therapeutics | $7.47M |
| XTLB | XTL Biopharmaceuticals | $6.83M |
| XCUR | Exicure | $6.61M |
| AIM | AIM ImmunoTech | $6.16M |
| APRE | Aprea Therapeutics Inc. Common stock | $6.10M |
| LGVN | Longeveron | $5.32M |
| EVGN | Evogene | $5.09M |
| CANF | Can-Fite Biopharma Ltd American Depositary Shares each representing two (2) | $4.92M |
| XBIO | Xenetic Biosciences | $4.80M |
| NCNA | NuCana plc American Depositary Share | $4.35M |
| BIAF | bioAffinity Technologies | $3.73M |
| ERNA | Ernexa Therapeutics | $3.22M |
| KALA | KALA BIO | $3.20M |
| MBIO | Mustang Bio | $3.03M |
| ENLV | Enlivex | $2.73M |
| DCOY | Decoy Therapeutics | $2.55M |
| CRIS | Curis | $2.46M |
| APVO | Aptevo Therapeutics | $2.43M |
| GNPX | Genprex | $1.84M |
| OGEN | Oragenics | $1.69M |
| GOVX | GeoVax Labs | $1.53M |
| MTNB | Matinas Biopharma Holdings | $1.48M |
| INO | Inovio Pharmaceuticals | |
| KPTI | Karyopharm Therapeutics |
The two-week call for each stock is on its stock page.
Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 2, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.